CureMetrix

curemetrix.com · San Diego, United States of America

CureMetrix is a medical imaging AI company that develops FDA-cleared software to assist radiologists in interpreting screening mammograms, improving cancer detection and workflow efficiency. Its cloud-based and on-premise solutions use deep learning to analyze breast images, flag suspicious regions, and provide quantitative scores that support clinical decision-making for hospitals, imaging centers, and health systems. The company generates revenue through software licensing and usage-based subscriptions to healthcare providers and partners.

  • Document & Vision AI
  • Electronic Health Records
  • Clinical Trial & Research Software
Revenue
$6.0M
Employees
45
Founded
2014
Headquarters
San Diego, United States of America

What 8 Arbolus experts think of CureMetrix

NPS scores are skewed toward the positive, with 25% of experts giving a perfect 10 and most scores clustering at 8-10. Renewal intent demonstrates a split: those with longer implementation (>1 year) and higher spends typically indicate positive renewal, while pilot-stage and mid-spend customers are not sure or negative. Stickiness is high among long-term users, especially in pharmaceutical R&D. Key sentiment drivers include perceived reliability, sustained rollout, and measurable benefits in operational environments.Overall Customer Sentiment: Positive

Who reviewed CureMetrix

Total customers 8 8 current · 0 former
Reviews growth +8 in six months
Seniority of respondents
  • C-Suite 57% (5)
  • Director 43% (3)
Operations Generalist C-Suite NPS 9
Engineering Partner Director NPS 10 Will renew
Operations Leader C-Suite NPS 8 Not renewing

Employer names and spend open once the report publishes.

Tell us when the CureMetrix report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

37 Net Promoter Score, from 8 scored reviews
  • Promoters 4
  • Passives 3
  • Detractors 1

Cumulative NPS by month

+0 over 4 months
  • Mar 8
  • Apr 9
  • May 9
  • Jun 8

Net Promoter Score across 2 reviews, accumulated up to each month. Category median 48 across 2 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 40%
  • Will renew 2
  • Undecided 2
  • Not renewing 1

Plan to renew, by seniority

  • C-Suite 0% 2 answers
  • Director 67% 3 answers
  • 9.5/10 Average score from customers who will renew
  • 6.5/10 Average score from undecided customers
  • 8/10 Average score from customers not renewing

Top alternatives

Most weighed by CureMetrix customers

For people who use CureMetrix

Do you use CureMetrix at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 8 customers of CureMetrix have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.